Personalize statin therapy following acute ischemic stroke
Drugs & Therapy Perspectives · 20.07.2026 · 42 (2) · 334-337
DOI: 10.1007/s40267-026-01268-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs & Therapy Perspectives, online erschienen am 20.07.2026. Verfasst von Michael B. Brown. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Statins are a cornerstone of secondary prevention following acute ischemic stroke (AIS). Widely used for their lipid-lowering effects, emerging evidence suggests the pleiotropic properties of statins provide a benefit in AIS management, including for patients with low baseline lipid levels. Established guidelines for statin therapy following AIS are inconsistent. Treatment optimization requires a personalised approach which considers stroke subtype and patient characteristics. Emerging strategies in statin care following AIS include novel drug-delivery systems improving bioavailability to the brain and combination therapies for patients with comorbid conditions or resistance to statin therapy.
Zitieren
APA
Brown, M. B. (2026). Personalize statin therapy following acute ischemic stroke. Drugs & Therapy Perspectives, 42(2), 334-337. https://doi.org/10.1007/s40267-026-01268-3
Vancouver
Brown MB. Personalize statin therapy following acute ischemic stroke. Drugs & Therapy Perspectives. 2026;42(2):334-337. doi:10.1007/s40267-026-01268-3
BibTeX
@article{Brown2026,
author = {Brown, Michael B.},
title = {Personalize statin therapy following acute ischemic stroke},
journal = {Drugs & Therapy Perspectives},
year = {2026},
volume = {42},
number = {2},
pages = {334--337},
doi = {10.1007/s40267-026-01268-3}
}
EUVIMED